Physician profile
Matthew J Roller
NPI 1033283379
$345.00
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.51 · 2020: $12.24 · 2021: $74.48 · 2022: $166 · 2023: $22.09 · 2024: $58.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $45.00 · Food and Beverage: $35.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $45.00 |
| Food and Beverage | $35.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $80.61 | 2023-2024 | |
| Celgene Corporation | $38.51 | 2022 | |
| Kyowa Kirin, INC. | $36.74 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $36.72 | 2020-2021 | |
| Abbvie INC. | $36.58 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $30.19 | 2021-2022 | |
| Biogen, INC. | $21.40 | 2021 | |
| Amgen INC. | $19.84 | 2022 | |
| Allergan, INC. | $17.01 | 2022 | |
| Tanabe Pharma America, INC. | $15.89 | 2022 | |
| Merz North America, INC. | $11.51 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Roller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.